DSN, higi introduce first-ever Fit Pharmacist Challenge

Drug Store News, in partnership with higi, is hosting the first-ever Fit Pharmacist Challenge, a series of fitness-tracking competitions that will reward winning pharmacists and pharmacy technicians. Read more ...

NACDS, U.S. Pain Foundation discuss Rx abuse, access in joint op-ed

The complex issues of prescription drug abuse and access are not receiving the comprehensive approach that they deserve and greater collaboration is needed among all stakeholders to help find solutions. Read More ...

Surescripts handled more transactions than Amex or PayPal in 2014

Surescripts processed 6.5 billion health-data transactions in 2014. Read More ...

PQA creates three measures to help track opioid prescriptions

The membership of the Pharmacy Quality Alliance has endorsed three new performance measures that assess the use of opioids from multiple providers or at high dosage in persons without cancer. Read More ...

Current news

The AARP Public Policy Institute’s latest Rx Price Watch Report shows that, despite an overall 4% decrease in price in 2013, the prices of generic drugs seem to be dropping at the slowest rate since 2006.
The U.S. Food and Drug Administration approved two treatments for Irritable Bowel Syndrome with Diarrhea (IBS-D) on Wednesday. Both Patheon Pharmaceuticals’ Viberzi (eluxadoline) and Salix Pharmaceuticals’ Xifaxan (ritaximin) are now available to patients.
Action on Smoking & Health recently launched an infomercial campaign behind its new faux product, The Wrinkler, which purports to add between 10 and 20 years of aging to a users face.
On Thursday Roxane Laboratories announced that its alosetron hydrochloride tablets — a generic version of irritable bowel syndrome treatment Lotronex — was available in 0.5- and 1-mg strength.
Fruth Pharmacy has unveiled new technology to make prescription label reading easier for the visually impaired by partnering with AccessaMed to bring a special prescription label into all 26 Fruth Pharmacy locations.
Some online pharmacy sites will soon be able to point visitors to their .pharmacy domain names.
Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg strength tablets.
One on Thursday announced the launch of Vanish Hyperthin condoms.
More than four in five consumers are planning on turning to the allergy aisle for relief of congestion or sneezing due to their allergies this year, but only one in four will have been influenced by a commercial in making their selection, according to the most recent Field Agent study, which recently surveyed more than 500 homeowners across five different U.s. regions on their allergy-related purchases.
In a new survey of approximately 2,700 American customers, the Canadian International Pharmacy Association found continued demand for safely ordering prescription medications online from licensed Canadian pharmacies.

CPE Monitor Reminders

As of May 1, 2014, ACPE-accredited CE Providers, such as Drug Store News, may no longer issue statements of credit. All credit awarded by ACPE-accredited providers to pharmacists and pharmacy technicians must be via CPE Monitor. Any statements obtained from the Drug Store News website are no longer valid statements of credit. You MUST obtain your statement of credit from CPE Monitor at MyCPEMonitor.net.

Please be sure that you enter your correct NABP e-PID number in your Drug Store News CE profile. This ensures your CE credit will be transmitted to CPE Monitor so you may receive credit for completed CPE activities. To look up your e-PID number go to the MyCPEMonitor.net or NABP.net site and search the system for their NABP e-PID number.